Laura Calabresi Selected Research

Sterol O-Acyltransferase 2

1/2022

Plasma FA composition in familial LCAT deficiency indicates SOAT2-derived cholesteryl ester formation in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Calabresi Research Topics

Disease

22	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 10/2023 - 06/2004
21	Atherosclerosis 03/2021 - 09/2002
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 02/2003
10	Dyslipidemias (Dyslipidemia) 01/2021 - 05/2008
8	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 11/2013 - 02/2002
6	Primary Myelofibrosis (Myelosclerosis) 01/2023 - 11/2017
6	Hypercholesterolemia 01/2022 - 09/2005
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 01/2014
4	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 04/2003
4	Anemia 08/2022 - 07/2011
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 01/2018
4	Acute Coronary Syndrome 01/2019 - 10/2003
4	Coronary Disease (Coronary Heart Disease) 06/2016 - 06/2002
4	Amyloidosis 01/2015 - 05/2004
4	Ischemia 02/2008 - 02/2003
4	Reperfusion Injury 09/2006 - 02/2003
3	Chronic Renal Insufficiency 10/2023 - 07/2020
3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2019
3	Cholesteryl Ester Transfer Protein Deficiency 09/2022 - 02/2002
3	Corneal Opacity 08/2022 - 07/2011
3	Kidney Diseases (Kidney Disease) 01/2022 - 01/2021
3	Essential Thrombocythemia 01/2021 - 01/2019
3	Neoplasms (Cancer) 01/2021 - 11/2017
3	Myocardial Infarction 01/2021 - 02/2013
3	ST Elevation Myocardial Infarction 01/2019 - 01/2009
3	Familial Amyloidosis (Hereditary Amyloidosis) 01/2015 - 05/2004
3	Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial) 05/2008 - 02/2004
3	Necrosis 02/2008 - 02/2003
3	Heart Neoplasms 02/2008 - 02/2003
3	Atherosclerotic Plaque (Atheroma) 12/2006 - 03/2006
2	Renal Insufficiency (Renal Failure) 07/2023 - 01/2022
2	Inborn Genetic Diseases (Disease, Hereditary) 07/2023 - 09/2019
2	Fibrosis (Cirrhosis) 01/2023 - 01/2022
2	Nephrotic Syndrome (Syndrome, Nephrotic) 08/2022 - 06/2004
2	Hypertension (High Blood Pressure) 08/2022 - 01/2018
2	Proteinuria 08/2022 - 01/2013
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2013
2	Homozygous Familial Hypercholesterolemia 01/2021 - 01/2017
2	Non-alcoholic Fatty Liver Disease 12/2020 - 12/2019
2	Inflammation (Inflammations) 11/2017 - 10/2017
2	Hypertriglyceridemia 11/2015 - 06/2010
2	Hepatocellular Carcinoma (Hepatoma) 09/2013 - 03/2004
2	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 05/2012 - 02/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 09/2006 - 01/2004
1	Type 2 Diabetes Mellitus (MODY) 10/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	2 Familial Hypobetalipoproteinemia 01/2023

Drug/Important Bio-Agent (IBA)

38	CholesterolIBA 11/2023 - 02/2002
28	LipidsIBA 01/2023 - 02/2003
27	HDL CholesterolIBA 11/2023 - 03/2006
25	HDL LipoproteinsIBA 11/2023 - 02/2003
16	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2023 - 02/2003
16	Lipoproteins (Lipoprotein)IBA 07/2023 - 02/2004
14	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 07/2023 - 06/2004
13	oxidized low density lipoproteinIBA 01/2022 - 04/2003
10	EnzymesIBA 01/2022 - 05/2006
8	ApolipoproteinsIBA 01/2021 - 09/2002
7	LDL CholesterolIBA 01/2020 - 08/2006
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2009
5	Apolipoproteins B (ApoB)IBA 10/2023 - 05/2012
5	Triglycerides (Triacylglycerol)IBA 01/2023 - 02/2005
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 02/2005
4	Apolipoproteins E (ApoE)IBA 10/2023 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2004
3	Lipoprotein-XIBA 07/2023 - 01/2016
3	Cholesterol Esters (Cholesteryl Esters)IBA 01/2022 - 10/2015
3	Apolipoprotein A-II (Apolipoprotein A2)IBA 01/2017 - 05/2004
3	Niacin (Nicotinic Acid)FDA LinkGeneric 11/2015 - 09/2013
3	Fenofibrate (CiL)FDA LinkGeneric 11/2015 - 06/2010
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2013 - 02/2005
3	Creatine Kinase (Creatine Phosphokinase)IBA 02/2008 - 02/2003
2	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 01/2013
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022 - 05/2004
2	CER-001IBA 01/2022 - 01/2021
2	Cholesterol Ester Transfer ProteinsIBA 03/2021 - 07/2012
2	red yeast riceIBA 01/2021 - 01/2014
2	BMS201038IBA 01/2021 - 01/2017
2	CalreticulinIBA 01/2021 - 01/2019
2	CytokinesIBA 01/2020 - 01/2016
2	Sterol Esterase (Hormone-Sensitive Lipase)IBA 12/2019 - 10/2015
2	Blood Proteins (Serum Proteins)IBA 01/2019 - 05/2004
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019 - 03/2006
2	Cell Adhesion MoleculesIBA 01/2017 - 11/2007
2	Nonsense Codon (Nonsense Mutation)IBA 07/2012 - 04/2003
2	Amyloid (Amyloid Fibrils)IBA 06/2011 - 12/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2008 - 02/2003
2	apolipoprotein A-I MilanoIBA 11/2007 - 02/2007
2	Apoprotein(a) (Apolipoprotein (a))IBA 09/2006 - 03/2006
2	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2004 - 02/2003
1	dapagliflozinIBA 10/2023
1	Protein Isoforms (Isoforms)IBA 10/2023
1	Apolipoprotein E3IBA 10/2023
1	Apolipoprotein E4IBA 10/2023
1	Apolipoprotein E2IBA 10/2023
1	romiplostim FDA Link 01/2023
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2023
1	OsteopontinIBA 01/2023

Therapy/Procedure

9	Therapeutics 01/2023 - 02/2003
2	Blood Component Removal (Apheresis) 01/2021 - 01/2017
2	Injections 09/2006 - 03/2006